Imamura N, Kusunoki Y, Kajihara H, Okada K, Kuramoto A
Department of Internal Medicine, Hiroshima University Hospital, Japan.
Acta Haematol. 1988;80(3):121-8. doi: 10.1159/000205617.
The morphology, immunologic and functional properties of peripheral blood and bone marrow cells or cultured cells from 2 patients with clinically aggressive non-T, non-B lymphoma/leukemia are described. The leukemic cells possessed medium to large granules in the cytoplasm, antigens against CD38, CD2, CD25, OKIa1, CD16, TA-1, CD9, CD24 and NKH-1 (N901) monoclonal antibodies on their cell surface, and also showed a high natural killer (NK) activity. Phenotypically, the cells in these disorders were quite different from T gamma leukemia cells bearing Fc receptor or the traditionally reported NK leukemia cells possessing HNK-1 (Leu 7) antigens on their surface. In addition, these leukemias/lymphomas belonged to neither T- nor B-cell lineage, proved by studying clonal gene rearrangement for the T beta and T gamma receptor, and immunoglobulin. Hence, a quite interesting and important point, as suggested by our data, is that all our cases expressed an antigen for NKH-1 (N901), which is detectable on all NK cell surfaces and they lacked the antigen for Leu 7 (HNK-1), which is usually detected on the surface of leukemic NK cells. These facts indicate that we are dealing with a leukemic NK cell subset which is quite different from cells of all other reported cases of NK cell leukemias. We therefore concluded that such disorders with an aggressive clinical nature and a poor prognosis as in our cases belong to a new clinical entity originating from a portion of the NK cell subset.(ABSTRACT TRUNCATED AT 250 WORDS)
本文描述了2例临床侵袭性非T、非B淋巴瘤/白血病患者外周血、骨髓细胞或培养细胞的形态学、免疫学及功能特性。白血病细胞胞质内有中等至大颗粒,细胞表面有针对CD38、CD2、CD25、OKIa1、CD16、TA-1、CD9、CD24和NKH-1(N901)单克隆抗体的抗原,且具有较高的自然杀伤(NK)活性。从表型上看,这些疾病中的细胞与带有Fc受体的Tγ白血病细胞或传统报道的表面带有HNK-1(Leu 7)抗原的NK白血病细胞有很大不同。此外,通过研究Tβ和Tγ受体以及免疫球蛋白的克隆基因重排证明,这些白血病/淋巴瘤既不属于T细胞系也不属于B细胞系。因此,正如我们的数据所表明的,一个非常有趣且重要的点是,我们所有的病例都表达了NKH-1(N901)抗原,该抗原可在所有NK细胞表面检测到,而它们缺乏Leu 7(HNK-1)抗原,该抗原通常在白血病NK细胞表面检测到。这些事实表明,我们正在处理一种白血病NK细胞亚群,它与所有其他报道的NK细胞白血病病例的细胞有很大不同。我们因此得出结论,像我们病例中具有侵袭性临床性质和不良预后的此类疾病属于源自NK细胞亚群一部分的一种新的临床实体。(摘要截短至250字)